Siegfried Barbera, SL recalls Votrient (pazopanib) 200 mg tablets
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Dissolution Specifications
- Products
-
- Votrient (pazopanib) 200 mg tablets
- Company
- Siegfried Barbera, SL
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 2016
- About this recall
- Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66